EcoR1 Capital’s Corcept Therapeutics CORT Stock Holding History

EcoR1 Capital’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-166,005	Closed	-$2.22M	–	45
2018 Q4	$2.22M	Buy	+166,005	New	+$2.19M	0.22%	44

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EcoR1 Capital's CORT Position: Q1 2019 in Review

EcoR1 Capital sold out of Corcept Therapeutics (CORT) in Q1 2019, closing a stake of 166,005 shares — an estimated $2.22M sold.

EcoR1 Capital first reported a position in CORT in Q4 2018 and held it in 1 quarter. The position peaked at $2.22M in Q4 2018. 208 funds tracked by Wall St. Rank hold CORT as of Q1 2019.

EcoR1 Capital reported no remaining Corcept Therapeutics position as of Q1 2019 after selling out during the quarter.
EcoR1 Capital sold 166,005 Corcept Therapeutics shares in Q1 2019, an estimated $2.22M.
EcoR1 Capital first reported a position in Corcept Therapeutics in Q4 2018 and held it in 1 quarter.
EcoR1 Capital's Corcept Therapeutics position peaked at $2.22M in Q4 2018.
208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2019.

Based on EcoR1 Capital's 13F filing for Q1 2019, filed 15 May 2019.